Astrana Health, Inc. (NASDAQ:ASTH) Short Interest Update

Astrana Health, Inc. (NASDAQ:ASTH) saw a large decrease in short interest in January. As of January 15th, there was short interest totalling 1,490,000 shares, a decrease of 8.6% from the December 31st total of 1,630,000 shares. Based on an average daily volume of 303,600 shares, the short-interest ratio is currently 4.9 days. Approximately 4.2% of the company’s stock are short sold.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on ASTH. Robert W. Baird raised their price target on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. KeyCorp began coverage on shares of Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Macquarie upgraded Astrana Health to a “hold” rating in a research note on Monday, December 16th. TD Cowen initiated coverage on Astrana Health in a research report on Monday, October 14th. They issued a “buy” rating and a $66.00 target price for the company. Finally, Truist Financial dropped their price target on Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a research report on Monday, January 13th. Two equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $63.67.

Astrana Health Stock Performance

ASTH traded up $0.05 during trading hours on Friday, hitting $36.87. The company’s stock had a trading volume of 315,669 shares, compared to its average volume of 367,344. The company has a 50-day simple moving average of $36.27 and a 200 day simple moving average of $46.37. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $2.07 billion, a PE ratio of 28.36, a PEG ratio of 1.42 and a beta of 1.20. Astrana Health has a fifty-two week low of $29.08 and a fifty-two week high of $63.20.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, hitting the consensus estimate of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The business had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. During the same quarter in the prior year, the company posted $0.47 earnings per share. As a group, sell-side analysts expect that Astrana Health will post 1.15 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ASTH. State Street Corp acquired a new stake in shares of Astrana Health during the third quarter worth $91,966,000. Geode Capital Management LLC acquired a new stake in Astrana Health during the 3rd quarter worth about $58,995,000. FMR LLC purchased a new stake in Astrana Health during the third quarter valued at about $48,413,000. SteelPeak Wealth LLC acquired a new position in shares of Astrana Health in the third quarter worth about $39,398,000. Finally, Loomis Sayles & Co. L P purchased a new position in shares of Astrana Health in the third quarter worth approximately $30,251,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.